Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Open accessPublished version of a preprint
The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index; 17 of the 28 sources its claims cite were checked for support.
Abstract
Abstract Ageing is the biggest risk factor for cardiovascular disease. Cellular senescence, a process driven in part by telomere shortening, has been implicated in age‐related tissue dysfunction. Here, we address the question of how senescence is induced in rarely dividing/post‐mitotic cardiomyocytes and investigate whether clearance of senescent cells attenuates age‐related cardiac dysfunction. During ageing, human and murine cardiomyocytes acquire a senescent‐like phenotype characterised by persistent DNA damage at telomere regions that can be driven by mitochondrial dysfunction and crucially can occur independently of cell division and telomere length. Length‐independent telomere damage in cardiomyocytes activates the classical senescence‐inducing pathways, p21 CIP and p16 INK4a , and results in a non‐canonical senescence‐associated secretory phenotype, which is pro‐fibrotic and pro‐hypertrophic. Pharmacological or genetic clearance of senescent cells in mice alleviates detrimental features of cardiac ageing, including myocardial hypertrophy and fibrosis. Our data describe a mechanism by which senescence can occur and contribute to age‐related myocardial dysfunction and in the wider setting to ageing in post‐mitotic tissues.
Overview
CoChat Summary
## TL;DR
The paper argues that ageing cardiomyocytes acquire a senescent-like state through persistent telomere-associated DNA damage that is independent of telomere shortening, cell division, and telomerase activity. Clearing senescent cells in mice reduced cardiomyocyte hypertrophy and fibrosis, suggesting a therapeutic angle for age-related cardiac dysfunction.
## Key findings
- In mouse and human hearts, mean telomere-associated foci (TAF) per cardiomyocyte and the percentage of cardiomyocytes with TAF increased significantly with age, while total γH2A.X foci did not change with age.
- In purified cardiomyocytes from young (3 months) vs old (20 months) mice, RNA-seq found 416 differentially expressed genes; principal component analysis separated the groups with the first two components explaining 80.1% and 7.8% of variance.
- Aged cardiomyocytes upregulated senescence markers and hypertrophy-related genes: p16Ink4a, p21CIP, and p15Ink4b increased, and hypertrophy genes including Myh7 and Acta1 increased, but canonical SASP genes such as Il-1α, Il-1β, Il-6, Cxcl1, and Cxcl2 were not differentially expressed.
- Senescent-cell clearance improved cardiac structure: in aged INK-ATTAC mice, AP treatment reduced p16Ink4a- and eGFP-positive cells, reduced TAF in cardiomyocytes, reduced average cardiomyocyte cross-sectional area, and decreased fibrosis; navitoclax likewise significantly reduced hypertrophy and fibrosis in aged wild-type mice.
- Navitoclax increased evidence of cardiomyocyte renewal: EdU-labelled cardiomyocytes increased from 0.07% in vehicle controls to 0.23% with navitoclax.
## Methods
- The study combined in vivo ageing and intervention experiments in mice with human heart tissue from patients undergoing open-heart surgery for aortic stenosis, plus multiple cell culture systems (rat neonatal cardiomyocytes, mouse embryonic cardiomyocytes, H9C2 myoblasts, and AC10 cells).
- Telomere damage was assessed mainly by dual immuno-FISH for DDR proteins (γH2A.X, 53BP1) co-localised with telomeres, along with STED microscopy, ChIP-qPCR for γH2A.X at telomeres, SA-β-Gal staining, RNA-seq, and cytokine assays.
- Causality was tested using telomere-targeted damage (TRF1-FokI), oxidative stress/mitochondrial dysfunction models, and senescent-cell clearance via INK-ATTAC/AP20187 and the senolytic navitoclax (ABT263).
## Limitations
- The paper states that interphase telomere FISH does not identify telomeres on specific chromosomes or detect telomere-free ends; it also notes that with 3-μm tissue sections, the entirety of cardiomyocyte nuclei may not be captured.
- The authors note that although STED improved resolution, clusters of telomeres may still not be fully resolved.
- Evident from the text: several mechanistic links are correlative rather than definitively causal in vivo, and the authors explicitly say it remains possible that mitochondrial dysfunction is a consequence, rather than the cause, of telomere dysfunction.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
12 Valid · 0 Not valid · 8 Not checked · 110 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Work by us and others previously demonstrated demonstrated that stress exposure leads to activation of a persistent DDR at telomeric regions”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Telomere damage is persistent in cardiomyocytes
What the sources say
- Supportedcites Fumagalli et al, 2012 matched to “Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation” (2012) source
The Results section on DDR markers during physiological ageing states that exposure to exogenous or endogenous DNA damage can produce breaks at telomeres that remain unrepaired, resulting in persistent DDR foci. This supports the claim when stress exposure refers to DNA-damaging stress. (LLM, conf=0.93)
- Supportedcites Hewitt et al, 2012 matched to “Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence” (2012) source
The paper reports that DNA damage foci induced by exogenous stress are preferentially located at telomeres and that persistent foci are associated with telomeres (Abstract). The Results section, “TAF are persistent in stress-induced senescence,” also reports enrichment of the DDR marker γH2A.X at telomere repeats 10 days after irradiation. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Coppé et al, 2008 matched to “Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor” (2008) source
The citation supports the description of these as pro-inflammatory SASP-associated genes, not the citing authors’ finding about young and aged cardiomyocytes. The paper describes inflammatory cytokines and chemokines as SASP components, including IL-6, and identifies IL-1α and IL-1β as SASP factors; the cardiomyocyte comparison is not attributed to it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS)”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Swanson et al, 2013 matched to “Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence” (2013) source
The Results section (‘Marked distension of satellite DNA in a subset of primary human fibroblasts’; page unavailable) identifies distended centromeric satellite signals using DNA hybridization. The section on senescent murine cells likewise reports distended centromeric signals and calls this change SADS. The age-dependent cardiomyocyte finding is explicitly the citing authors’ own observation (‘we also observed’), not a finding attributed to this source. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In mouse models of accelerated telomere shortening, critically short telomeres have been shown to repress PGC1‐α‐ and β‐mediated mitochondrial biogenesis (Sahin et al, 2011; Chang et al, 2016).”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Supportedcites Sahin et al, 2011 matched to “Telomere dysfunction induces metabolic and mitochondrial compromise” (2011) source
The section “Telomere dysfunction represses PGC network and mitochondrial biogenesis” describes successive generations of telomerase-deficient mice with decreasing telomere reserves and reports reduced PGC-1α and PGC-1β expression in mice with severe telomere dysfunction. The Discussion states that these analyses established a link between telomere dysfunction and repression of PGC-dependent mitochondrial biogenesis. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Supportedcites Chang et al, 2016 matched to “Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy” (2016) source
The Results (Fig. 3 legend, p. —) state 'Critically short telomeres lead to activation of p53, leading to decreased mitochondrial biogenesis' with reduced Pgc1α and Pgc1β transcripts, and the Results text concludes that 'critically shortened telomeres in dystrophin-deficient cardiomyocytes in conjunction with a DNA damage response block mitochondrial biogenesis.' The Discussion additionally describes the TERT G4 null mouse model of ubiquitous telomere shortening developing mitochondrial dysfunction 'because of p53-dependent inhibition of PGC1α/β,' and the Significance section summarizes reduced mitochondrial biogenesis via p53 activation in the humanized-telomere mdx4cv/mTR model. Thus the mouse-model attribution of short-telomere repression of PGC1α/β-mediated mitochondrial biogenesis is stated in our copy. (LLM, conf=0.90)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our study, in accordance with others (Baker et al, 2016; Roos et al, 2016; Demaria et al, 2017), shows that the loss of senescent cardiomyocytes does not adversely alter cardiac function in aged mice.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Partly supportedcites Baker et al, 2016 matched to “Naturally occurring p16Ink4a-positive cells shorten healthy lifespan” (2016) sourceExperimental — accuracy not yet measured
The section “p16Ink4a-positive cells contribute to cardiac aging” (page not provided) reports no significant difference in resting echocardiographic measures between treated and untreated 18-month-old mice, and preserved cardiac stress tolerance after treatment. But the paper describes clearance of p16Ink4a-positive cells, not specifically the loss of senescent cardiomyocytes; the identified senescence-marker-positive cardiac cells include pericardial epithelial cells and fibroblasts and aortic-root smooth muscle cells. (LLM, conf=0.88)
- Could not verifycites Roos et al, 2016 matched to “Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice” (2016) sourceExperimental — accuracy not yet measured
The age-related vascular pathology section reports clearance of senescent cells from the aortic vessel wall and improved carotid artery relaxation in aged mice. The copy does not report loss of senescent cardiomyocytes or assess whether their loss adversely affects cardiac function (searched: cardiomyocytes, cardiac function, heart function, echocardiography). (LLM, conf=0.74)
- Partly supportedcites Demaria et al, 2017 matched to “Cellular senescence promotes adverse effects of chemotherapy and cancer relapse” (2017) sourceExperimental — accuracy not yet measured
In Results (“Inflammation, bone marrow recovery and heart function”; page unavailable), eliminating senescent cells after doxorubicin treatment almost completely prevented declines in cardiac function. But the paper says those cardiac senescent cells were primarily endothelial cells and fibroblast-like cells, not cardiomyocytes. It therefore does not establish that loss of senescent cardiomyocytes is harmless in aged mice. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
60 more claims
Create a free account to see all 130 claims and to verify the 4 references still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 46
- The quote only partly states this claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“genetic and pharmacological clearance of p16-expressing senescent cells ameliorated heart functions in aged mice140.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [140]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice, despite having long telomeres and ubiquitous telomerase expression, show an age-dependent increase in dysfunctional telomeres in both proliferating and non-proliferating tissues20,34–37.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the levels of DDR markers and TAFs increase during ageing in different mammalian tissues.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The clearance of senescent cells in aged mice improves heart functions and reduces the fraction of TAF-positive cardiomyocytes without a significant effect on mean telomere length36.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clearance of senescent cells in aged mice and in mice with atherosclerosis using genetic and pharmacological approaches improves vascular and myocardial function and attenuates age-dependent remodelling.25,27”
From The costs and benefits of senotherapeutics for human health (2022) · cites this paper as [27]
Experimental — accuracy not yet measured
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Hearts from mixed‐sex CJ57/BL6 mice were placed on a Langendorff setup.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Mixed‐sex C57BL/6 mice were analysed at either 3, 15, 20, 24 or 30 months of age.”
Citations
Cites
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Senescence-associated b -galactosidase activity assay SA-b -Gal activity assay was performed as described previously (Dimri et al , 1995).”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · cited 1×
“Telomere shortening has been proposed as a major inducer of senescence (Bodnar et al , 1998).”
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationHucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060 · cited 1×
“The models were encoded in the Systems Biology Markup Language (SBML) modelling standard (Hucka et al , 2003) with the Python SBML shorthand tool (Wilkinson, 2011).”
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“…associated with a protein complex known as shelterin (de Lange, 2005), which facilitates the formation of a lariat-like structure to shield the exposed end of DNA (Griffith et al , 1999), thus protecting the ends of chromosomes from being recognised as DNA damage (d’Adda di Fagagna et al , 2003).”
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 3×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 1×
“Furthermore, we found a significant increase in TAF in CMs from Polg mut/mut mice, a model of accelerated ageing due to mitochondrial dysfunction (Trifunovic et al , 2004; Fig 6G).”
Cited by
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
“Senescent cardiomyocytes play pivotal roles in conduction abnormalities, increased pacing frequency, mitochondrial dysfunction, increased oxidative stress, and metabolic dysfunction.(227) Interestingly, senescent cardiomyocytes have been demonstrated to maintain cell-intrinsic senescence and induce neighboring healthy…”
BackgroundSenolytic drugs: from discovery to translation
Kirkland, J. L., & Tchkonia, T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13141 · Cited by 1,227
Self-citationCellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Self-citationTelomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Self-citationA guide to assessing cellular senescence in vitro and in vivo
González‐Gualda, E., Baker, A. G., Fruk, L., & Muñoz‐Espín, D. (2021) · The FEBS Journal · doi:10.1111/febs.15570 · Cited by 645
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Telomeres: history, health, and hallmarks of aging
Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637
“Additionally, although telomere shortening per se generates TIFs, ROS-induced guanine modification also produces TIFs, reflecting uncapping from shelterin disengagement (Anderson et al., 2019).”
BackgroundThe role of cellular senescence in ageing and endocrine disease
Khosla, S., Farr, J. N., Tchkonia, T., & Kirkland, J. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0335-y · Cited by 523
Self-citationMechanisms and consequences of endothelial cell senescence
Bloom, S. I., Islam, M. T., Lesniewski, L. A., & Donato, A. J. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00739-0 · Cited by 495
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
SenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
“Numerous senescence markers have been identified in postmitotic cells such as neurons 99 , cardiomyocytes 60 , osteocytes 93 , adipocytes 270 and others, and their levels in these cells have been observed to increase with age.”
Self-citationOgrodnik, M. (2021) · Aging Cell · doi:10.1111/acel.13338 · Cited by 349
“…based SA- β- gal Heart ~10% FC- based p16 (GFP) Inguinal Fat ~5% Ogrodnik et al. (2017) DSBs Liver (hepatocytes) ~15% Telomere- associated DSBs Liver (hepatocytes) ~15% Anderson et al. (2019) Telomere- associated DSBs Heart (cardiomyocytes) 50– 70% colorimetric SA- β- gal Heart…”
BackgroundInfluentialSelf-citationSenolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span
Robbins, P. D., Jurk, D., Khosla, S., Kirkland, J. L., LeBrasseur, N. K., Miller, J. D., Passos, J. F., Pignolo, R. J., Tchkonia, T., & Niedernhofer, L. J. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-050120-105018 · Cited by 360
“, cytometry by time of flight (CyTOF) (35) or single-cell omics such as single-cell RNA sequencing (36)] are needed.”
BackgroundSelf-citationCellular senescence: at the nexus between ageing and diabetes
Palmer, A. K., Gustafson, B., Kirkland, J. L., & Smith, U. (2019) · Diabetologia · doi:10.1007/s00125-019-4934-x · Cited by 337
Self-citationCellular senescence: all roads lead to mitochondria
Martini, H., & Passos, J. F. (2023) · The FEBS Journal · doi:10.1111/febs.16361 · Cited by 334
Self-citationSenescence mechanisms and targets in the heart
Chen, M. S., Lee, R. T., & Garbern, J. C. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab161 · Cited by 327
Mitochondrial dysfunction and cell senescence: deciphering a complex relationship
Chapman, J., Fielder, E., & Passos, J. F. (2019) · FEBS Letters · doi:10.1002/1873-3468.13498 · Cited by 325
Self-citationThe role of cellular senescence in cardiac disease: basic biology and clinical relevance
Mehdizadeh, M., Aguilar, M., Thorin, E., Ferbeyre, G., & Nattel, S. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00624-2 · Cited by 304
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 274
Liu, J., Ding, Y., Liu, Z., & Liang, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00258 · Cited by 270
A Senescence-Centric View of Aging: Implications for Longevity and Disease
Borghesan, M., Hoogaars, W. M. H., Varela-Eirin, M., Talma, N., & Demaria, M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.002 · Cited by 267
“Importantly, ablation of senescent cells in aged mice using the INK-ATTAC mouse model or senolytics (D+Q or navitoclax) resulted in a decrease of fibrosis and hypertrophy and increase in smaller proliferating cardiomyocytes, suggesting that removal of senescent cardiomyocytes and/or cardiac progenitor cells could resc…”
BackgroundMethodTargeting Age-Related Pathways in Heart Failure
Li, H., Hastings, M. H., Rhee, J., Trager, L. E., Roh, J. D., & Rosenzweig, A. (2020) · Circulation Research · doi:10.1161/circresaha.119.315889 · Cited by 266
Cellular senescence and Alzheimer disease: the egg and the chicken scenario
Saez-Atienzar, S., & Masliah, E. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0325-z · Cited by 257
Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy
Kaludercic, N., & Di Lisa, F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00012 · Cited by 263
Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction
Victorelli, S., Lagnado, A., Halim, J., Moore, W., Talbot, D., Barrett, K., Chapman, J., Birch, J., Ogrodnik, M., Meves, A., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2019101982 · Cited by 258
“The accumulation of DDR proteins at telomeres that are not critically short has been previously reported in non-dividing cells, such as neurons (Fumagalli et al , 2012; Ogrodnik et al , 2019), cardiomyocytes (Anderson et al , 2019) and hepatocytes (Hewitt et al , 2012).”
InfluentialSelf-citationNAD + Metabolism in Cardiac Health, Aging, and Disease
Abdellatif, M., Sedej, S., & Kroemer, G. (2021) · Circulation · doi:10.1161/circulationaha.121.056589 · Cited by 255
Walaszczyk, A., Dookun, E., Redgrave, R., Tual‐Chalot, S., Victorelli, S., Spyridopoulos, I., Owens, A., Arthur, H. M., Passos, J. F., & Richardson, G. D. (2019) · Aging Cell · doi:10.1111/acel.12945 · Cited by 250
Self-citationCellular senescence at the crossroads of inflammation and Alzheimer's disease
Guerrero, A., De Strooper, B., & Arancibia-Cárcamo, I. L. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.06.007 · Cited by 236
Mitochondria in the signaling pathways that control longevity and health span
Akbari, M., Kirkwood, T. B. L., & Bohr, V. A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100940 · Cited by 230
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging
Linders, A. N., Dias, I. B., López Fernández, T., Tocchetti, C. G., Bomer, N., & Van der Meer, P. (2024) · npj Aging · doi:10.1038/s41514-024-00135-7 · Cited by 231
“With age, an increase in DDR proteins was observed in the telomeres, independent from shortening 45,88 .”
BackgroundNLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice
Marín‐Aguilar, F., Lechuga‐Vieco, A. V., Alcocer‐Gómez, E., Castejón‐Vega, B., Lucas, J., Garrido, C., Peralta‐Garcia, A., Pérez‐Pulido, A. J., Varela‐López, A., Quiles, J. L., et al. (2020) · Aging Cell · doi:10.1111/acel.13050 · Cited by 220
“Interestingly, DNA damage in dysfunctional telomeres is a key hallmark of cardiomyocytes with a senescent‐like phenotype (Anderson et al., 2019), and clearance of senescence cells in mice alleviates cardiac deterioration with aging (Anderson et al., 2019; Lewis‐McDougall et al., 2019).”
BackgroundCardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments
Tang, X., Li, P.-H., & Chen, H.-Z. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00280 · Cited by 216
“Senescent cardiomyocytes increased expression of SASP factors including CCN family member 1 (CCN1), interleukins (IL1α, IL1β, and IL6), tumor necrosis factor-alpha (TNFα), and monocyte chemoattractant protein-1 (MCP1), endothelin 3 (Edn3), tumor growth factor-beta (TGFβ), and growth and differentiation factor 15 (GDF1…”
BackgroundInfluentialNeutrophils induce paracrine telomere dysfunction and senescence in ROS‐dependent manner
Lagnado, A., Leslie, J., Ruchaud‐Sparagano, M., Victorelli, S., Hirsova, P., Ogrodnik, M., Collins, A. L., Vizioli, M. G., Habiballa, L., Saretzki, G., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106048 · Cited by 211
“Furthermore, our previous work demonstrated that telomere DNA damage is irreparable and leads to a persistent DDR during cellular senescence (Fumagalli et al, 2012; Hewitt et al, 2012; Anderson et al, 2019).”
Self-citationTuttle, C. S. L., Waaijer, M. E. C., Slee‐Valentijn, M. S., Stijnen, T., Westendorp, R., & Maier, A. B. (2020) · Aging Cell · doi:10.1111/acel.13083 · Cited by 211
“…subgrouped by tissue (a) and marker type (b) demonstrated within several other postmitotic tissues such as adipose (Minamino et al., 2009; Oubaha et al., 2016), osteoclasts and osteoblasts (Farr et al., 2016, 2017), cardiomyocytes (Anderson et al., 2019), and ganglion cells (Oubaha et al., 2016).”
BackgroundCharacterization of cellular senescence in aging skeletal muscle
Zhang, X., Habiballa, L., Aversa, Z., Ng, Y. E., Sakamoto, A. E., Englund, D. A., Pearsall, V. M., White, T. A., Robinson, M. M., Rivas, D. A., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00250-8 · Cited by 206
Self-citationIske, J., Seyda, M., Heinbokel, T., Maenosono, R., Minami, K., Nian, Y., Quante, M., Falk, C. S., Azuma, H., Martin, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18039-x · Cited by 211
Self-citationImmune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
Song, P., An, J., & Zou, M.-H. (2020) · Cells · doi:10.3390/cells9030671 · Cited by 198
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models
Roh, J., Hill, J. A., Singh, A., Valero-Muñoz, M., & Sam, F. (2022) · Circulation Research · doi:10.1161/circresaha.122.320257 · Cited by 189
Fracture Healing in the Setting of Endocrine Diseases, Aging, and Cellular Senescence
Saul, D., & Khosla, S. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac008 · Cited by 185
P16INK4A—More Than a Senescence Marker
Safwan-Zaiter, H., Wagner, N., & Wagner, K.-D. (2022) · Life · doi:10.3390/life12091332 · Cited by 181
“For example, elevated p16 expression and betagalactosidase activity were found in cardiomyocytes gathered from Langendorff heart perfusion with aging [91].”
BackgroundOn the evolution of cellular senescence
Kowald, A., Passos, J. F., & Kirkwood, T. B. L. (2020) · Aging Cell · doi:10.1111/acel.13270 · Cited by 179
“Senescent post-mitotic cells have been shown to express genes such as p21 and p16 involved in cell-cycle arrest and have a SASP (Anderson et al., 2019; Farr et al., 2017; Jurk et al., 2012).”
BackgroundInfluentialSelf-citationMetabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications
Xie, S., Xu, S.-C., Deng, W., & Tang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01378-8 · Cited by 177
Cellular Senescence in Cardiovascular Diseases: A Systematic Review
Hu, C., Zhang, X., Teng, T., Ma, Z.-G., & Tang, Q.-Z. (2022) · Aging and disease · doi:10.14336/ad.2021.0927 · Cited by 174
“With aging, the myocytes exhibit impaired metabolic flexibility and excessive mitochondrial ROS production, which resulting in DNA damage and telomere dysregulation [29].”
BackgroundInfluentialClearance of senescent cells during cardiac ischemia–reperfusion injury improves recovery
Dookun, E., Walaszczyk, A., Redgrave, R., Palmowski, P., Tual‐Chalot, S., Suwana, A., Chapman, J., Jirkovsky, E., Donastorg Sosa, L., Gill, E., et al. (2020) · Aging Cell · doi:10.1111/acel.13249 · Cited by 173
Self-citationEndometrial receptivity in women of advanced age: an underrated factor in infertility
Pathare, A. D. S., Loid, M., Saare, M., Gidlöf, S. B., Zamani Esteki, M., Acharya, G., Peters, M., & Salumets, A. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmad019 · Cited by 173
“Cellular senescence is the irreversible cell cycle arrest of not only proliferative cells but also post-mitotic cells (Sapieha and Mallette, 2018; Anderson et al. , 2019; Maduro et al. , 2021).”
BackgroundCellular senescence in cardiac diseases
Shimizu, I., & Minamino, T. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.05.002 · Cited by 167
Stress-induced biological aging: A review and guide for research priorities
Polsky, L. R., Rentscher, K. E., & Carroll, J. E. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.05.016 · Cited by 165
Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies
Lucas, V., Cavadas, C., & Aveleira, C. A. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000622 · Cited by 160
The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
Wagner, K.-D., & Wagner, N. (2022) · Cells · doi:10.3390/cells11121966 · Cited by 156
Dissecting Aging and Senescence—Current Concepts and Open Lessons
Schmeer, C., Kretz, A., Wengerodt, D., Stojiljkovic, M., & Witte, O. W. (2019) · Cells · doi:10.3390/cells8111446 · Cited by 144
“The signature combination of factors released by senescent cells depends on the cell type and the inducer of senescence [60,78]; however, many key effectors are shared.”
BackgroundKaempferol: Paving the path for advanced treatments in aging-related diseases
Hussain, M. S., Altamimi, A. S. A., Afzal, M., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., Gupta, G., Shahwan, M. J., Kukreti, N., Wong, L. S., et al. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112389 · Cited by 155
“Senescent cardiomyocytes play a pivotal role in this process, contributing to conduction alterations, enhanced pacing level, heightened OS, mitochondrial dysfunction, and metabolic dysfunction (Anderson et al., 2019).”
The costs and benefits of senotherapeutics for human health
Raffaele, M., & Vinciguerra, M. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00300-7 · Cited by 140
Spatial mapping of cellular senescence: emerging challenges and opportunities
Gurkar, A. U., Gerencser, A. A., Mora, A. L., Nelson, A. C., Zhang, A. R., Lagnado, A. B., Enninful, A., Benz, C., Furman, D., Beaulieu, D., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00446-6 · Cited by 141
Self-citationTargeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss
Chandra, A., Lagnado, A. B., Farr, J. N., Monroe, D. G., Park, S., Hachfeld, C., Tchkonia, T., Kirkland, J. L., Khosla, S., Passos, J. F., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3978 · Cited by 138
Self-citationTelomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening
Barnes, R. P., de Rosa, M., Thosar, S. A., Detwiler, A. C., Roginskaya, V., Van Houten, B., Bruchez, M. P., Stewart-Ornstein, J., & Opresko, P. L. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00790-y · Cited by 127
“Cardiomyocytes from mice, and hippocampal neurons and hepatocytes in baboon, show increased DDR positive telomeres with age, with no appreciable shortening despite the presence of senescence markers (Anderson et al., 2019; Fumagalli et al., 2012).”
BackgroundZhuang, L., Xia, W., Chen, D., Ye, Y., Hu, T., Li, S., & Hou, M. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00716-0 · Cited by 125
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Evangelou, K., Vasileiou, P. V. S., Papaspyropoulos, A., Hazapis, O. G., Petty, R., Demaria, M., & Gorgoulis, V. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00007.2022 · Cited by 135
Chandra, A., Lagnado, A. B., Farr, J. N., Doolittle, M., Tchkonia, T., Kirkland, J. L., LeBrasseur, N. K., Robbins, P. D., Niedernhofer, L. J., Ikeno, Y., et al. (2022) · Aging Cell · doi:10.1111/acel.13602 · Cited by 120
Self-citationDel Rey, M. J., Valín, Á., Usategui, A., Ergueta, S., Martín, E., Municio, C., Cañete, J. D., Blanco, F. J., Criado, G., & Pablos, J. L. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0169-4 · Cited by 119
Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.03.019 · Cited by 114
“, 2014) cause proliferating (Campisi, 2005; Campisi and d’Adda di Fagagna, 2007; Hayflick and Moorehead, 1961), as well as terminally differentiated, non-dividing cells (Anderson et al., 2019; Farr et al., 2016; Jurk et al., 2012, 2014) to undergo profound chromatin, transcriptomic, and secretome changes, replicative…”
BackgroundSelf-citationA common signature of cellular senescence; does it exist?
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101458 · Cited by 135
Wu, Z., Qu, J., & Liu, G.-H. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00775-3 · Cited by 118
“Furthermore, in senescent post-mitotic cells such as neurons and cardiomyocytes, persistent telomeric DNA damage, irrespective of length, is frequently observed 122,124 (Fig.”
Revisiting the Hallmarks of Aging to Identify Markers of Biological Age
Guerville, F., De Souto Barreto, P., Ader, I., Andrieu, S., Casteilla, L., Dray, C., Fazilleau, N., Guyonnet, S., Langin, D., Liblau, R., et al. (2020) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2019.50 · Cited by 116
“Indeed, data from human and mice suggest a contribution of telomere damage to lung and cardiomyocyte aging, independently of telomere length (28, 29).”
BackgroundSelf-citationCellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity
Berlanga‐Acosta, J., Guillén, G. E., Rodríguez-Rodríguez, N., Mendoza‐Marí, Y., Bringas-Vega, M. L., Berlanga-Saez, J. O., Herrera, D. G. D. B., Martínez-Jiménez, I., Hernandez-Gutierrez, S., & Valdes-Sosa, P. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573032 · Cited by 131
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 134
“In turn, ROS may cause difficult-to-repair damage at telomeres as well as telomere length-independent senescence in post-mitotic cells, as reported for cardiomyocytes and other cell types (Anderson et al., 2019; Fumagalli et al., 2012; Hewitt et al., 2012).”
BackgroundMarino, F., Salerno, N., Scalise, M., Salerno, L., Torella, A., Molinaro, C., Chiefalo, A., Filardo, A., Siracusa, C., Panuccio, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021132 · Cited by 138
“The SASP has been postulated as a pathophysiological link between diabetes and senescence in cardiovascular diseases [22,23,31].”
BackgroundDysregulated Phenylalanine Catabolism Plays a Key Role in the Trajectory of Cardiac Aging
Czibik, G., Mezdari, Z., Altintas, D. M., Bréhat, J., Pini, M., d’Humières, T., Delmont, T., Radu, C., Breau, M., Liang, H., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.054204 · Cited by 124
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison-Hughes, G. M., Tchkonia, T., & Kirkland, J. L. (2023) · Cells · doi:10.3390/cells12091296 · Cited by 112
“INK-ATTAC Navitoclax Alleviated myocardial hypertrophy and fibrosis [54]”
BackgroundInfluentialSelf-citationExpansion and Cell-Cycle Arrest: Common Denominators of Cellular Senescence
Ogrodnik, M., Salmonowicz, H., Jurk, D., & Passos, J. F. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.06.011 · Cited by 104
Self-citationKuo, C., Pilling, L. C., Kuchel, G. A., Ferrucci, L., & Melzer, D. (2019) · Aging Cell · doi:10.1111/acel.13017 · Cited by 107
Monoamine oxidases in age-associated diseases: New perspectives for old enzymes
Santin, Y., Resta, J., Parini, A., & Mialet-Perez, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101256 · Cited by 105
Self-citationSenescence and senolytics in cardiovascular disease: Promise and potential pitfalls
Owens, W. A., Walaszczyk, A., Spyridopoulos, I., Dookun, E., & Richardson, G. D. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111540 · Cited by 122
Self-citationTargeting senescent cells for a healthier longevity: the roadmap for an era of global aging
Sun, Y., Li, Q., & Kirkland, J. L. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac030 · Cited by 105
Self-citationTripathi, U., Misra, A., Tchkonia, T., & Kirkland, J. L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111548 · Cited by 104
“…fate that entails an essentially permanent cell cycle arrest in response to multiple factors, including repeated replication, potentially oncogenic mutations and activated oncogenes, DNA damage, metabolic insults, damage/danger signals, neutrophils, radiation, and cytotoxic and other drugs [1–4].”
Self-citationSystemic Aging Fuels Heart Failure: Molecular Mechanisms and Therapeutic Avenues
Fang, Z., Raza, U., Song, J., Lu, J., Yao, S., Liu, X., Zhang, W., & Li, S. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14947 · Cited by 135
“50 Hence, targeting senescence and SASP factors in the context of aging and chronic HF provides a promising therapeutic avenue.”
InfluentialPrinciples of the Molecular and Cellular Mechanisms of Aging
da Silva, P. F. L., & Schumacher, B. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.11.018 · Cited by 100
Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease
Camacho-Encina, M., Booth, L. K., Redgrave, R. E., Folaranmi, O., Spyridopoulos, I., & Richardson, G. D. (2024) · Cells · doi:10.3390/cells13040353 · Cited by 108
“…3 (Edn3), tumour growth factor-beta (TGF β ), and growth and differentiation factor 15 (GDF15) have been clinically linked with age-related myocardial ischemia and infarction [4,17,150]. mtROS are a component of the SASP [151], and functional mitochondria are critical for SASP production.”
BackgroundInfluentialSelf-citationEnglund, D. A., Zhang, X., Aversa, Z., & LeBrasseur, N. K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111595 · Cited by 94
Self-citationTargeting cellular senescence in cancer and aging: roles of p53 and its isoforms
Beck, J., Turnquist, C., Horikawa, I., & Harris, C. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa071 · Cited by 92
“For example, senescent cells have been shown to induce fibrosis through the activation of fibroblasts (28,156,157).”
BackgroundDissecting primary and secondary senescence to enable new senotherapeutic strategies
Admasu, T. D., Rae, M. J., & Stolzing, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101412 · Cited by 102
Tripathi, U., Nchioua, R., Prata, L. G. P. L., Zhu, Y., Gerdes, E. O. W., Giorgadze, N., Pirtskhalava, T., Parker, E., Xue, A., Espindola-Netto, J. M., et al. (2021) · Aging · doi:10.18632/aging.203560 · Cited by 88
Self-citationCardiac Aging: From Basic Research to Therapeutics
Yan, M., Sun, S., Xu, K., Huang, X., Dou, L., Pang, J., Tang, W., Shen, T., & Li, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9570325 · Cited by 89
“confirmed that telomere injury resulted in cardiomyocyte senescence and was independent of telomere length [70].”
BackgroundInduction of Accelerated Aging in a Mouse Model
Cai, N., Wu, Y., & Huang, Y. Y. (2022) · Cells · doi:10.3390/cells11091418 · Cited by 105
“SAMP8 mice also showed accumulated amyloid and age-related microtubule-associated protein tau (MAPT) hyperphosphorylation, as well as increased nitric oxide synthase activity, further demonstrating their feasibility as a brain aging model [68,69].”
BackgroundDeryabin, P. I., Griukova, A., Nikolsky, N. N., & Borodkina, A. V. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03374-0 · Cited by 96
“More recent data provide evidence that senescence is not specific only to proliferating cells, but may also occur in post-mitotic cells, such as cardiomyocytes and glial cells [8, 9].”
BackgroundEmerging insights in senescence: pathways from preclinical models to therapeutic innovations
Mansfield, L., Ramponi, V., Gupta, K., Stevenson, T., Mathew, A. B., Barinda, A. J., Herbstein, F., & Morsli, S. (2024) · npj Aging · doi:10.1038/s41514-024-00181-1 · Cited by 88
The hallmarks of aging as a conceptual framework for health and longevity research
Tartiere, A. G., Freije, J. M. P., & López-Otín, C. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1334261 · Cited by 118
Lérida‐Viso, A., Estepa‐Fernández, A., Morellá‐Aucejo, Á., Lozano‐Torres, B., Alfonso, M., Blandez, J. F., Bisbal, V., Sepúlveda, P., García‐Fernández, A., Orzáez, M., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106356 · Cited by 87
Salerno, N., Marino, F., Scalise, M., Salerno, L., Molinaro, C., Filardo, A., Chiefalo, A., Panuccio, G., Angelis, A. D., Urbanek, K., et al. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111740 · Cited by 87
Targeting senescent cells to attenuate cardiovascular disease progression
Song, P., Zhao, Q., & Zou, M.-H. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101072 · Cited by 76
Fibrotic pathways and fibroblast-like synoviocyte phenotypes in osteoarthritis
Damerau, A., Rosenow, E., Alkhoury, D., Buttgereit, F., & Gaber, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1385006 · Cited by 95
“In pulmonary fi brosis, the senescence of fi broblasts is evident (186), while senescence of other cell lineages such as macrophages, chondrocytes or cardiomyocytes have been related to various aging associated pathologies such as OA or cardiomyopathy (184, 187).”
BackgroundCellular senescence in the aging brain: A promising target for neurodegenerative diseases
Sahu, M. R., Rani, L., Subba, R., & Mondal, A. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111675 · Cited by 75
Targeting cellular senescence in metabolic disease
Palmer, A. K., Tchkonia, T., & Kirkland, J. L. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101601 · Cited by 79
Self-citationAnti‐inflammatory treatment rescues memory deficits during aging in nfkb1−/− mice
Fielder, E., Tweedy, C., Wilson, C., Oakley, F., LeBeau, F. E. N., Passos, J. F., Mann, D. A., von Zglinicki, T., & Jurk, D. (2020) · Aging Cell · doi:10.1111/acel.13188 · Cited by 71
“…of DNA damage response (DDR) proteins with telomeres, has also been shown to increase in multiple mammalian tissues during aging and age-related diseases (Anderson et al., 2019; Birch et al., 2015; Hewitt et al., 2012) and is generally believed to be a robust marker of cellular senescence.”
BackgroundResultSelf-citationUryga, A. K., Grootaert, M. O. J., Garrido, A. M., Oc, S., Foote, K., Chappell, J., Finigan, A., Rossiello, F., d’Adda di Fagagna, F., Aravani, D., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02123-z · Cited by 73
Cellular senescence in age-related disorders
Kaur, J., & Farr, J. N. (2020) · Translational research · doi:10.1016/j.trsl.2020.06.007 · Cited by 85
“(49) With regards to heart tissue, recent work by Anderson et al.(68) showed that with aging, both human and murine post-mitotic cardiomyocytes acquire a senescence-like phenotype characterized particularly by DNA damage at telomere regions.”
Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
Redgrave, R. E., Dookun, E., Booth, L. K., Camacho-Encina, M., Folaranmi, O., Tual‐Chalot, S., Gill, J. H., Owens, W. A., Spyridopoulos, I., Passos, J. F., et al. (2023) · npj Aging · doi:10.1038/s41514-023-00113-5 · Cited by 85
Self-citationTherapeutic Potential of Senolytics in Cardiovascular Disease
Dookun, E., Passos, J. F., Arthur, H. M., & Richardson, G. D. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07075-w · Cited by 69
“More recently it has been demonstrated that senescence contributes directly to age-related myocardial remodelling in mice, as pharmacogenetic elimination of senescent cells, using the p16-INKATTAC model, reduced myocardial fibrosis and attenuated cardiomyocyte hypertrophy [17, 25].”
BackgroundSelf-citationModulation of fracture healing by the transient accumulation of senescent cells
Saul, D., Monroe, D. G., Rowsey, J. L., Kosinsky, R. L., Vos, S. J., Doolittle, M. L., Farr, J. N., & Khosla, S. (2021) · eLife · doi:10.7554/elife.69958 · Cited by 71
Cellular Senescence: Mechanisms, Morphology, and Mouse Models
Beck, J. A., Horikawa, I., & Harris, C. C. (2020) · Veterinary Pathology · doi:10.1177/0300985820943841 · Cited by 87
“Through the use of these models, the contributory roles of cellular senescence and the beneficial effects of senolysis have been demonstrated in several ageassociated diseases including tau-related neuropathology and cognitive decline,(19) chemotherapy-induced fatigue,(38) cancer recurrence,(38) osteoporosis,(42) myoc…”
BackgroundMethod
Metadata
- Authors
- Anderson, R., Lagnado, A., Maggiorani, D., Walaszczyk, A., Dookun, E., Chapman, J., Birch, J., Salmonowicz, H., Ogrodnik, M., Jurk, D., Proctor, C., Correia‐Melo, C., Victorelli, S., Fielder, E., Berlinguer‐Palmini, R., Owens, A., Greaves, L. C., Kolsky, K. L., Parini, A., Douin‐Echinard, V., LeBrasseur, N. K., Arthur, H. M., Tual‐Chalot, S., Schafer, M. J., Roos, C. M., Miller, J. D., Robertson, N., Mann, J., Adams, P. D., Tchkonia, T., Kirkland, J. L., Mialet‐Perez, J., Richardson, G. D., & Passos, J. F.
- Affiliations
- Newcastle University (GB)
- Inserm (FR)
- Mayo Clinic (US)
- Wellcome Centre for Mitochondrial Research (GB)
- Cancer Research UK Scotland Institute (GB)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- ORCID
- Lagnado, Anthony
- Maggiorani, Damien
- Walaszczyk, Anna
- Dookun, Emily
- Chapman, James
- Birch, Jodie
- Salmonowicz, Hanna
- Ogrodnik, Mikolaj
- Jurk, Diana
- Proctor, Carole
- Correia‐Melo, Clara
- Victorelli, Stella
- Fielder, Edward
- Berlinguer‐Palmini, Rolando
- Greaves, Laura C
- Parini, Angelo
- Douin‐Echinard, Victorine
- LeBrasseur, Nathan K
- Arthur, Helen M
- Tual‐Chalot, Simon
- Schafer, Marissa J
- Miller, Jordan D
- Robertson, Neil
- Mann, Jelena
- Adams, Peter D
- Kirkland, James L
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- Venue
- The EMBO Journal
- Published
- 2019-02-08
- Volume
- 38
- Issue
- 5
- Pages
- e100492
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC6396144
- OpenAlex
- W2913284769
- Semantic Scholar
- f2b575f4b8dabea90337c591a95d86658c57701d
- Cited by
- 532
- References
- 60
- Citations by year
- 2026: 59 · 2025: 80 · 2024: 83 · 2023: 68 · 2022: 77 · 2021: 70 · 2020: 67 · 2019: 28
- FWCI
- 41.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Connor Group
- Noaber Foundation
- Région Occitanie, France
- Medical Research Council and Arthritis UK funded centre for integrated Musculoskeletal Ageing (MR/K0063121/1)
- RCUK | Biotechnology and Biological Sciences Research Council (BB/H022384/1, BB/K017314/1)
- British Heart Foundation (PG/15/85/31744)
- Foundation for the National Institutes of Health (AG013925)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- cardiomyocyte senescence, cellular senescence, cardiac aging, senolytics, senescence-associated secretory phenotype, p21, p16INK4a, mitochondrial dysfunction, myocardial fibrosis, cardiac hypertrophy, age-related cardiac dysfunction
- MeSH terms
- Aging, Animals, DNA Damage, Female, Fibrosis, Cardiomegaly, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Mitosis, Monoamine Oxidase, Phenotype, RNA, Cellular Senescence, Rats, Sprague-Dawley, Mice, Knockout, Telomerase, Myocytes, Cardiac, Mice, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.